About Hansen Medical (NASDAQ:HNSN)
Hansen Medical, Inc. is engaged in the development and marketing of medical devices. The Company develops, manufactures and sells a range of medical robotics designed for positioning, manipulation and stable control of catheters and catheter-based technologies. Its products include Sensei Robotic Catheter System (Sensei system), Artisan Extend Control Catheter, CoHesion 3D Visualization Module and Magellan System. Its Sensei system allows physicians to navigate catheters in interventional procedures within the atrial heart chambers. Its disposable Artisan Extend catheter assembly consists of a telescoping set of control catheters. Its CoHesion 3D Visualization Module is a software interface between its Sensei system and the St. Jude Medical EnSite System for Electro-Physiology procedures. The Magellan System controls the Magellan Robotic Catheter, which is a telescoping, steerable catheter designed to facilitate remote catheter navigation and vessel cannulation.
Industry, Sector and Symbol:
- Sector: Healthcare
- Industry: Advanced Medical Equipment & Technology
- Sub-Industry: Health Care Equipment
- Symbol: NASDAQ:HNSN
- CUSIP: 41130710
- Web: www.hansenmedical.com/
Average Prices:- 50 Day Moving Avg: $3.98
- 200 Day Moving Avg: $3.26
P/E:- Trailing P/E Ratio: N/A
- Foreward P/E Ratio: -28.50
- P/E Growth: 0.00
Profitability:- Net Margins: -317.95%
- Return on Assets: -96.52%
Misc:
Frequently Asked Questions for Hansen Medical (NASDAQ:HNSN)
What is Hansen Medical's stock symbol?
Hansen Medical trades on the NASDAQ under the ticker symbol "HNSN."
How were Hansen Medical's earnings last quarter?
Hansen Medical, Inc. (NASDAQ:HNSN) issued its earnings results on Thursday, November, 5th. The company reported ($0.54) earnings per share for the quarter, topping the consensus estimate of ($0.90) by $0.36. The business had revenue of $3.18 million for the quarter. The business's quarterly revenue was down 18.0% on a year-over-year basis. During the same quarter in the previous year, the business earned ($1.30) earnings per share. View Hansen Medical's Earnings History.
Who are some of Hansen Medical's key competitors?
Some companies that are related to Hansen Medical include Thermo Fisher Scientific (TMO), Danaher Corporation (DHR), Intuitive Surgical (ISRG), Boston Scientific Corporation (BSX), Koninklijke Philips N.V. (PHG), Illumina (ILMN), Cerner Corporation (CERN), Edwards Lifesciences Corporation (EW), Agilent Technologies (A), Waters Corporation (WAT), ResMed (RMD), Hologic (HOLX), Varian Medical Systems (VAR), PerkinElmer (PKI), ABIOMED (ABMD), Bruker Corporation (BRKR), Alere (ALR) and Quidel Corporation (QDEL).
Who owns Hansen Medical stock?
Hansen Medical's stock is owned by a variety of of retail and institutional investors. Top institutional investors include
FEINBERG LARRY N
(26.67%). Company insiders that own Hansen Medical stock include Brian Sheahan, Cary Guy Vance and Robert O Cathcart. View Institutional Ownership Trends for Hansen Medical.
How do I buy Hansen Medical stock?
Shares of Hansen Medical can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Hansen Medical's stock price today?
One share of Hansen Medical stock can currently be purchased for approximately $3.99.
MarketBeat Community Rating for Hansen Medical (NASDAQ HNSN)MarketBeat's community ratings are surveys of what our community members think about Hansen Medical and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
Consensus Ratings for Hansen Medical (NASDAQ:HNSN) (How are Consensus Ratings Calculated?) MarketBeat calculates consensus ratings using the most recent rating from each brokerage that has rated a stock within the last twelve months. Since brokers often use different ratings systems, each rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings. Each stock's consensus rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months.
MarketBeat will no longer include ratings and price target data in its consensus calculation if a broker drops coverage and MarketBeat has received a report that coverage was dropped. Ratings from certain research firms that issue ratings using purely quantitative methods (such as Zacks, Vetr and ValuEngine) are not included in consensus calculations. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
| Ratings Breakdown: | No ratings tracked in the last 12 months. |
| Consensus Rating: | N/A (Score: NaN) |
| Consensus Price Target: | N/A |
Consensus Price Target History for Hansen Medical (NASDAQ:HNSN)
Analysts' Ratings History for Hansen Medical (NASDAQ:HNSN)
Show:
No equities research coverage for this company has been tracked by MarketBeat.com
Earnings History for Hansen Medical (NASDAQ:HNSN)Earnings History by Quarter for Hansen Medical (NASDAQ HNSN)| Date | Quarter | Consensus Estimate | Actual EPS | Revenue Estimate | Actual Revenue | Release Link | Conference Call | Details |
|---|
| 11/5/2015 | Q315 | ($0.90) | ($0.54) | | $3.18 million | View | N/A |  |
| 8/6/2015 | Q2 | ($0.10) | ($0.06) | $6.20 million | $3.09 million | View | N/A | |
| 5/7/2015 | Q1 15 | ($0.10) | ($0.07) | $6.20 million | $5.79 million | View | N/A | |
| 2/23/2015 | Q4 | ($0.09) | ($0.09) | | $5.03 million | View | N/A | |
| 11/6/2014 | Q314 | ($0.10) | ($0.13) | $5.70 million | $3.90 million | View | N/A | |
| 7/31/2014 | Q214 | ($0.11) | ($0.11) | $5.57 million | $6.90 million | View | Listen | |
| 5/7/2014 | Q114 | ($0.11) | ($0.14) | $4.94 million | $3.69 million | View | Listen | |
| 2/20/2014 | Q413 | ($0.14) | ($0.12) | $5.90 million | $5.60 million | View | Listen | |
| 8/7/2013 | Q2 2013 | ($0.05) | ($0.20) | $31.38 million | $3.34 million | View | Listen | |
| 5/8/2013 | Q1 2013 | ($0.13) | ($0.26) | $5.76 million | $2.95 million | View | Listen | |
| 2/27/2013 | Q4 2012 | ($0.14) | $0.15 | $5.92 million | $4.34 million | View | Listen | |
| 11/7/2012 | Q312 | ($0.16) | ($0.14) | $5.00 million | $5.10 million | View | N/A | |
| 8/8/2012 | | ($0.16) | ($0.19) | | | View | N/A | |
| 5/2/2012 | | ($0.18) | ($0.20) | | | View | N/A | |
| 2/22/2012 | | ($0.17) | ($0.16) | | | View | N/A | |
| 11/2/2011 | | ($0.15) | ($0.18) | | | View | N/A | |
| 8/3/2011 | | ($0.18) | ($0.16) | | | View | N/A | |
| 5/5/2011 | | ($0.19) | $0.21 | | | View | N/A | |
| 2/23/2011 | | ($0.20) | ($0.20) | | | View | N/A | |
(Data available from 1/1/2011 forward)
Earnings Estimates for Hansen Medical (NASDAQ:HNSN)Current Year EPS Consensus Estimate: $-2.40 EPS
Next Year EPS Consensus Estimate: $-0.14 EPS
Dividend History for Hansen Medical (NASDAQ:HNSN)
No dividend announcements for this company have been tracked by MarketBeat.com
Insider Trading and Institutional Ownership History for Hansen Medical (NASDAQ:HNSN)Insider Trades by Quarter for Hansen Medical (NASDAQ:HNSN)| Transaction Date | Insider Name | Title | Buy/Sell | Number of Shares | Average Share Price | Total Transaction | Details |
|---|
| 6/8/2016 | Brian Sheahan | VP | Sell | 166 | $3.99 | $662.34 | |
| 6/8/2016 | Cary Guy Vance | CEO | Sell | 596 | $3.99 | $2,378.04 | |
| 3/7/2016 | Brian Sheahan | VP | Sell | 161 | $2.51 | $404.11 | |
| 2/12/2016 | Brian Sheahan | VP | Sell | 3,472 | $2.34 | $8,124.48 | |
| 2/12/2016 | Robert O Cathcart | SVP | Sell | 284 | $2.34 | $664.56 | |
| 5/12/2015 | Larry N Feinberg | Major Shareholder | Buy | 18,888,681 | $0.65 | $12,277,642.65 | |
| 12/10/2014 | Nadim Yared | Director | Buy | 15,000 | $0.65 | $9,750.00 | |
| 12/3/2014 | William Mitchell Sutton | COO | Buy | 25,000 | $0.75 | $18,750.00 | |
| 11/12/2014 | Cary Guy Vance | CEO | Buy | 75,000 | $0.83 | $62,250.00 | |
| 5/20/2014 | Christopher Lowe | CEO | Buy | 20,000 | $1.44 | $28,800.00 | |
| 5/13/2014 | Nadim Yared | Director | Buy | 2,143 | $1.19 | $2,550.17 | |
| 3/11/2014 | Michael Eagle | Director | Buy | 10,000 | $2.29 | $22,900.00 | |
| 3/3/2014 | Susan Leonard | VP | Sell | 20,415 | $2.37 | $48,383.55 | |
| 2/27/2014 | William Mitchell Sutton | COO | Sell | 14,959 | $2.37 | $35,452.83 | |
| 2/26/2014 | Peter Mariani | CFO | Sell | 43,435 | $2.30 | $99,900.50 | |
| 8/8/2013 | Larry Feinberg | major shareholder | Buy | 8,101,810 | $1.23 | $9,965,226.30 | |
| 7/30/2013 | Stephen L Newman | Director | Buy | 81,301 | $1.23 | $100,000.23 | |
| 5/13/2013 | Larry N Feinberg | Major Shareholder | Buy | 37,363 | $1.52 | $56,791.76 | |
| 5/13/2013 | Nadim Yared | Director | Buy | 3,000 | $1.66 | $4,980.00 | |
| 3/12/2013 | Larry N Feinberg | Major Shareholder | Buy | 65,900 | $2.15 | $141,685.00 | |
| 3/5/2013 | Bruce Barclay | CEO | Sell | 19,194 | $2.24 | $42,994.56 | |
| 3/5/2013 | Carolyn M Bruguera | VP | Sell | 7,408 | $2.24 | $16,593.92 | |
| 3/5/2013 | Joseph James Guido | Insider | Sell | 4,802 | $2.24 | $10,756.48 | |
| 3/5/2013 | Peter J Mariani | CFO | Sell | 7,424 | $2.24 | $16,629.76 | |
| 3/1/2013 | Larry N Feinberg | Major Shareholder | Buy | 95,353 | $2.23 | $212,637.19 | |
| 2/21/2013 | Larry N Feinberg | Major Shareholder | Buy | 35,000 | $2.33 | $81,550.00 | |
| 1/24/2013 | Larry N Feinberg | Major Shareholder | Buy | 27,660 | $2.53 | $69,979.80 | |
| 1/15/2013 | Larry N Feinberg | Major Shareholder | Buy | 74,191 | $2.20 | $163,220.20 | |
| 12/27/2012 | Larry N Feinberg | Major Shareholder | Buy | 29,300 | $2.00 | $58,600.00 | |
| 12/21/2012 | Larry N Feinberg | Major Shareholder | Buy | 25,000 | $2.15 | $53,750.00 | |
| 12/11/2012 | Larry N Feinberg | Major Shareholder | Buy | 69,901 | $2.25 | $157,277.25 | |
| 11/28/2012 | Larry N Feinberg | Major Shareholder | Buy | 66,780 | $2.20 | $146,916.00 | |
| 11/8/2012 | Larry N Feinberg | Major Shareholder | Buy | 178,452 | $2.24 | $399,732.48 | |
| 10/26/2012 | Larry N Feinberg | Major Shareholder | Buy | 100,843 | $1.79 | $180,508.97 | |
| 10/25/2012 | Larry N Feinberg | Major Shareholder | Buy | 170,000 | $1.74 | $295,800.00 | |
| 10/17/2012 | Larry N Feinberg | Major Shareholder | Buy | 155,155 | $1.83 | $283,933.65 | |
(Data available from 1/1/2013 forward)
Headline Trends for Hansen Medical (NASDAQ:HNSN)
Latest Headlines for Hansen Medical (NASDAQ:HNSN)
| Source: |
|
Loading headlines, please wait.
Hansen Medical (HNSN) Chart for Sunday, October, 22, 2017
